Biogen (BIIB) Change in Acquisitions & Divestments (2009 - 2026)

Biogen (BIIB) has reported Change in Acquisitions & Divestments for 18 consecutive years, with $500000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $500000.0; the TTM figure through Mar 2026 stood at $23.5 million (up 142.27% YoY), while the FY2025 annual figure was $23.0 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments came in at $500000.0 for Q1 2026 at Biogen, up from -$33.6 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $5.7 billion in Q3 2023, with the low at -$96.7 million in Q4 2024.
• Average Change in Acquisitions & Divestments over 5 years is $791.1 million, with a median of $231.6 million recorded in 2023.
• Across the five-year window, Change in Acquisitions & Divestments jumped 246.8% in 2023 and tumbled 99.85% in 2024, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $566.3 million in 2022, then jumped by 906.29% to $5.7 billion in 2023, then slumped by 101.7% to -$96.7 million in 2024, then jumped by 65.25% to -$33.6 million in 2025, then surged by 101.49% to $500000.0 in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $500000.0, -$33.6 million, and $56.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.